Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy study-Reference-Cited by-同舟云学术

Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy study

Published:2016-09-27 Issue:6 Volume:41 Page:695-702
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Kjeldsen S. E.¹,Dzongowski P.²,Li N.³,Wang L.³,Radlmaier A.⁴

Affiliation:

1. Oslo University Hospital Ullevaal; University of Oslo; Oslo Norway

2. Milestone Research; London East Medical Centre; London ON Canada

3. Bayer Pharma AG; Beijing China

4. Bayer Pharma AG; Berlin Germany

Funder

Bayer Pharma AG

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12451/fullpdf

Reference23 articles.

1. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8);James;JAMA,2014

2. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC);Mancia;Eur Heart J,2013

3. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension;Weber;J Hypertens,2014

4. Current perspectives on combination therapy in the management of hypertension;Mallat;Integr Blood Press Control,2013

5. Hypertension management 2011: optimal combination therapy;Sever;Eur Heart J,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of bioequivalence, safety, and tolerability of a fixed-dose combination of nifedipine GITS and candesartan compared with the corresponding loose-dose combination under fed conditions;Int. Journal of Clinical Pharmacology and Therapeutics;2019-08-01